Abstract:Oncogenesis is the result of accumulation of specific gene mutations. Two classes of specific cancer mutations are distinguished: namely those affecting anti-oncogenes and those in which oncogenes are involved. Anti-oncogenes are thought to regulate normal growth by encoding proteins that inhibit the expression of the oncogenes. This is in line with the observation that tumor cells are often homozygous for a defect in an anti-oncogene, as this will allow the expression of an oncogene. In this paper we attempt to calculate the number of anti-oncogenes involved in the genesis of a malignant tumour cell. These calculations were initially performed using a simplified model for oncogenesis and later applied to more complicated situations. These calculations indicate that usually four mutations in anti-oncogenes are required for oncogenesis in adults. This is in contradiction to the well-known 2-hit model of oncogenesis of Knudson which predicts about 10(9) times more de novo arising tumour cells than are observed in reality. Oncogenesis is only observed in proliferating cells. Cell proliferation and growth kinetics in various organs differ greatly. Therefore the time of oncogenesis and tumour manifestation also varies in the different organs. In organs that develop in early life (e.g. retina and neurons of the brain) mitotic activity ceases soon after birth. Consequently neural and retinal tumours emerge only early in life. In contrast, the main development of the female breast occurs after puberty, and the earliest breast tumours will become apparent in young adults. The four recessive mutations in anti-oncogenes required for oncogenesis imply that probably recessive mutations are involved in two loci. It is clear that an inherited mutation in an anti-oncogene at a particular locus causes different tumour types depending on the various organs in which the tumours arise. Comparison of (a) results of calculations about the number of malignant neuroendocrine tumour cells that arise in a pancreatic islet of a patient with inherited MEN1-syndrome with (b) the pathological anatomy of such a patient, suggests that a cell with two or three oncogenic mutations has a growth advantage over normal cells. This leads to cell proliferation in a premalignant lesion until the set of four oncogenic mutations is complete. The clinically premalignant lesions have a maximal mean diameter of about 0.4 cm when the first true malignant tumour cell develops, and the pathologist will probably note malignancy when the lesion has the size of 1-2 cm.(ABSTRACT TRUNCATED AT 400 WORDS)

"The nighttime might be the right time" for cardiovascular event prediction.

Oncogenesis by mutations in anti-oncogenes: a view.

Top‐Down Approach to Study Chemical and Electronic Properties of Perovskite Solar Cells: Sputtered Depth Profiling Versus Tapered Cross‐Sectional Photoelectron Spectroscopies

Ion Compensation of Buried Interface Enables Highly Efficient and Stable Inverted MA‐Free Perovskite Solar Cells

Improved evaluation of deep-level transient spectroscopy on perovskite solar cells reveals ionic defect distribution

Have a SNAK. Encoding Spatial Information with the Spatial Non-alignment Kernel

More is Different: Mobile Ions Improve the Design Tolerances of Perovskite Solar Cells

Metastable interphase induced pre-strain compensation enables efficient and stable perovskite solar cells

Understanding How Ambiance Affects the Performance of Hole-Conductor-Free Perovskite Solar Cells from a Chemical Perspective

Probing elemental diffusion and radiation tolerance of perovskite solar cells via non-destructive Rutherford backscattering spectrometry

The Impacts and Origins of A-site Instability in Formamidinium-Cesium Lead Iodide Perovskite Solar Cells Under Extended Operation

Probing the Photovoltage and Photocurrent in Perovskite Solar Cells with Nanoscale Resolution

Steric Impediment of Ion Migration Contributes to Improved Operational Stability of Perovskite Solar Cells

Interfacial Proton Precompensation: Suppressing Deprotonation‐Driven Lattice Collapse for Enhanced Efficiency and Stability in Perovskite Solar Cells

Emerging Conductive Atomic Force Microscopy for Metal Halide Perovskite Materials and Solar Cells

XPS of the surface chemical environment of CsMAFAPbBrI trication-mixed halide perovskite film

Managing Multiple Halide-Related Defects for Efficient and Stable Inorganic Perovskite Solar Cells

In Situ Cesium Modification at Interface Enhances the Stability of Perovskite Solar Cells

The compatibility of methylammonium and formamidinium in mixed cation perovskite: the optoelectronic and stability properties

FIB’n’SIMS – Advanced Depth Analysis on Hybrid Organic-Inorganic Nanomaterials

High-Fill-Factor Perovskite Solar Cells via Pseudohalide Salt Modification of the Substrate to Mitigate Nonradiative Recombination at the Interface